Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_274590824

Sanofi accuses MSD of US patent infringement

September 19, 2016
Sales and Marketing MSD, Sanofi, lawsuit

Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …

News
shutterstock_141299494

Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia

September 16, 2016
Medical Communications University of Glasgow, chronic myeloid leukaemia

Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News
c_gajus_-_fotolia

Teva and Intel team up to tackle Huntington’s with wearable tech

September 16, 2016
Medical Communications Huntington's, Intel, Teva, wearable tech

Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …

News
shutterstock_512649

Dechra signs £31 million acquisition

September 16, 2016
Medical Communications Apex Laboratories, Dechra, acquisition

Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …

News
novo_corp_hq2

Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk

September 16, 2016
Medical Communications Novo Nordisk, diabetes, semaglutide

Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …

News
Cirrus

Cirrus – a new name for specialist artwork services

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …

News
Press release
sanofi-dr-frank-nestle-250

New immunology and inflammation research global head and North American CSO for Sanofi

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment

Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …

Appointment
eli_lilly_logo

Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …

Appointment
allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Feature
hero-plus

Mylan CEO to appear before US congress over EpiPen scandal

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …

News
gsk-house-location-building

GSK’s shingles vaccine tops MSD rival in Ph III testing

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …

News
eisa0001

EU approval for Eisai kidney cancer treatment

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, Eisai, Kisplyx, Lenvima, everolimus

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …

News

Bayer acquires Monsanto in largest-ever deal by a German company

September 14, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

Bayer and Monsanto have signed a definitive merger agreement under which the German drugmaker will acquire the US agricultural group …

News
sanofi_hq__boetie_hall

Sanofi reveals promising data for FDA-delayed diabetes drug

September 14, 2016
Research and Development, Sales and Marketing FDA, Lantus, Sanofi, iglarlixi

Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …

News

Bayer raises bid yet again to finalise Monsanto deal

September 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing

Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …

News
images

Roche’s Ocrevus more effective than Merck’s Rebif, company claims

September 14, 2016
Research and Development Merck, Ocrevus, Rebif, Roche, multiple sclerosis

Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …

News
entrance_takeda_i020_v1

Takeda reportedly sets $15bn on US acquisitions

September 14, 2016
Manufacturing and Production, Research and Development Takeda, acquisitions

Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …

News
shutterstock_168864905

Novartis joins $17m funding of chronic inflammatory disease startup

September 14, 2016
Research and Development Fountain Healthcare, Novartis, start up financing

Novartis was one of the co-leaders in the $17million series A financing of Irish startup in the development of chronic …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026